OptimizeRx Corp Quarterly Depreciation in USD from Q1 2012 to Q1 2014

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
OptimizeRx Corp annual/quarterly Depreciation history and growth rate from Q1 2012 to Q1 2014.
  • OptimizeRx Corp Depreciation for the quarter ending March 31, 2014 was $1.37K, a 2.7% decline year-over-year.
  • OptimizeRx Corp Depreciation for the twelve months ending March 31, 2014 was $5.59K, a 0.13% increase year-over-year.
  • OptimizeRx Corp annual Depreciation for 2023 was $99.8K, a 16.5% increase from 2022.
  • OptimizeRx Corp annual Depreciation for 2022 was $85.7K, a 18.6% decline from 2021.
  • OptimizeRx Corp annual Depreciation for 2021 was $105K, a 10.7% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2014 $5.59K $1.37K -$38 -2.7% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-15
Q4 2013 $5.63K $1.41K +$25.00 +1.81% Oct 1, 2013 Dec 31, 2013 10-K/A 2015-09-16
Q3 2013 $5.6K $1.41K +$25.00 +1.81% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-14
Q2 2013 $5.58K $1.41K -$5 -0.35% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-12
Q1 2013 $5.58K $1.41K +$107 +8.23% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 $5.48K $1.38K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 $1.38K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $1.41K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 $1.3K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.